Frances Frankenburg | Profiles RNS

Frances R. Frankenburg, MD

Professor

Boston University Chobanian & Avedisian School of Medicine

Psychiatry

MD, University of Toronto

Websites

	ResearchGate
	McLean Hospital
	Harvard Catalyst

Frances R. Frankenburg, MD, completed her medical and psychiatry training at the University of Toronto, and came to Boston in 1982. She worked at McLean Hospital, first as a research fellow and then as a staff psychiatrist, until 1995. She is now chief of Inpatient and Consultation-Liaison Psychiatry at the Bedford VA and a professor of Psychiatry at the Chobanian and Avedisian School of Medicine.

Bedford VA - Edith Nourse Rogers Memorial VA Hosp

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Zanarini MC, Hein KE, Temes CM, Frankenburg FR, Fitzmaurice GM. Pathways to Health Reported by Patients With Borderline Personality Disorder With a Good Overall Outcome Versus a Fair-Poor Outcome Over 24 Years of Prospective Follow-Up. J Pers Disord. 2023 Aug; 37(4):456-468. PMID: 37721779

Frankenburg FR, Malvesti S. Paliperidone and Edema. J Clin Psychopharmacol. 2022 Mar-Apr 01; 42(2):225-226. PMID: 34176871

Frankenburg FR. One Fictional Opioid Overdose in Eighteenth-century England and One Attempted Opioid Overdose in Nineteenth-century America. J Addict Med. 2022 Jul-Aug 01; 16(4):379-381. PMID: 34653061

Shah R, Temes CM, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Levels of Depersonalization and Derealization Reported by Recovered and Non-recovered Borderline Patients Over 20 Years of Prospective Follow-up. J Trauma Dissociation. 2020 May-Jun; 21(3):337-348. PMID: 32000616; PMCID: PMC9423009; DOI: 10.1080/15299732.2020.1719259;

Ridolfi ME, Temes CM, Fraser EK, Frankenburg FR, Zanarini MC. Perceived Caretaker Malevolence During Childhood Reported by Borderline Patients and Personality-Disordered Comparison Subjects: Description and Prediction. J Pers Disord. 2020 10; 34(5):699-707. PMID: 31609186

Hathaway DB, Frankenburg F. Diurnal Variability in Neutrophil Counts in Clozapine Treatment: A Case Report and Review of the Literature. J Clin Psychopharmacol. 2019 Sep/Oct; 39(5):506-508. PMID: 31433342

Zanarini MC, Hörz-Sagstetter S, Temes CM, Frankenburg FR, Hein KE, Reich DB, Fitzmaurice GM. The 24-year course of major depression in patients with borderline personality disorder and personality-disordered comparison subjects. J Affect Disord. 2019 11 01; 258:109-114. PMID: 31400625

Temes CM, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Deaths by Suicide and Other Causes Among Patients With Borderline Personality Disorder and Personality-Disordered Comparison Subjects Over 24 Years of Prospective Follow-Up. J Clin Psychiatry. 2019 01 22; 80(1). PMID: 30688417

Zanarini MC, Temes CM, Frankenburg FR, Reich DB, Fitzmaurice GM. Levels of Acceptance and Forgiveness Reported by Patients With BPD and Personality-Disordered Comparison Subjects Over 20 Years of Prospective Follow-Up. J Pers Disord. 2020 04; 34(2):262-272. PMID: 30649991; PMCID: PMC6635099; DOI: 10.1521/pedi_2019_33_395;

Gad MA, Pucker HE, Hein KE, Temes CM, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Facets of identity disturbance reported by patients with borderline personality disorder and personality-disordered comparison subjects over 20 years of prospective follow-up. Psychiatry Res. 2019 01; 271:76-82. PMID: 30469092; PMCID: PMC6996594; DOI: 10.1016/j.psychres.2018.11.020;

Showing 10 of 106 results. Show More

Borkum DB, Frankenburg FR, Fitzmaurice GM, Athanasiadi A, Temes CM, Reich B, Zanarini MC. Predictors of Slower Time-to-Cessation of Individual Therapy for Borderline Patients Over 16 Years of Prospective Follow-Up. J Pers Disord. 2019 02; 33(1):135-144. PMID: 29505389

Zanarini MC, Temes CM, Frankenburg FR, Reich DB, Fitzmaurice GM. Description and prediction of time-to-attainment of excellent recovery for borderline patients followed prospectively for 20 years. Psychiatry Res. 2018 04; 262:40-45. PMID: 29407567; PMCID: PMC6025755; DOI: 10.1016/j.psychres.2018.01.034;

Zanarini MC, Temes CM, Ivey AM, Cohn DM, Conkey LC, Frankenburg FR, Fitzmaurice GM. The 10-year course of adult aggression toward others in patients with borderline personality disorder and axis II comparison subjects. Psychiatry Res. 2017 06; 252:134-138. PMID: 28264784; PMCID: PMC5438885; DOI: 10.1016/j.psychres.2017.02.054;

Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice GM. Fluidity of the Subsyndromal Phenomenology of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up. Am J Psychiatry. 2016 07 01; 173(7):688-94. PMID: 26869248; PMCID: PMC4930411; DOI: 10.1176/appi.ajp.2015.15081045;

Niesten IJ, Karan E, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Description and prediction of the income status of borderline patients over 10???years of prospective follow-up. Personal Ment Health. 2016 11; 10(4):285-292. PMID: 26864557

Karan E, Niesten IJ, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Prevalence and course of sexual relationship difficulties in recovered and non-recovered patients with borderline personality disorder over 16?years of prospective follow-up. Personal Ment Health. 2016 08; 10(3):232-43. PMID: 26864454

Zanarini MC, Weingeroff JL, Frankenburg FR, Fitzmaurice GM. Development of the self-report version of the Zanarini Rating Scale for Borderline Personality Disorder. Personal Ment Health. 2015 Nov; 9(4):243-9. PMID: 26174588; PMCID: PMC4609276; DOI: 10.1002/pmh.1302;

Zanarini MC, Frankenburg FR, Bradford Reich D, Harned AL, Fitzmaurice GM. Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow-up. J Clin Psychopharmacol. 2015 Feb; 35(1):63-7. PMID: 25384261; PMCID: PMC4276426; DOI: 10.1097/JCP.0000000000000232;

Zanarini MC, Frankenburg FR, Fitzmaurice GM. Severity of anxiety symptoms reported by borderline patients and Axis II comparison subjects: description and prediction over 16 years of prospective follow-up. J Pers Disord. 2014 Dec; 28(6):767-77. PMID: 24932876; PMCID: PMC4250411; DOI: 10.1521/pedi_2014_28_141;

Zanarini MC, Frankenburg FR, Reich DB, Conkey LC, Fitzmaurice GM. Treatment rates for patients with borderline personality disorder and other personality disorders: a 16-year study. Psychiatr Serv. 2015 Jan 01; 66(1):15-20. PMID: 25270039; PMCID: PMC4283568; DOI: 10.1176/appi.ps.201400055;

Martinho E, Fitzmaurice GM, Frankenburg FR, Zanarini MC. Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up. J Clin Psychopharmacol. 2014 Aug; 34(4):499-503. PMID: 24875066; PMCID: PMC4077949; DOI: 10.1097/JCP.0000000000000132;

Biskin RS, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Pain in patients with borderline personality disorder. Personal Ment Health. 2014 Aug; 8(3):218-27. PMID: 25044742; PMCID: PMC4129454; DOI: 10.1002/pmh.1265;

Zanarini MC, Frankenburg FR, Reich DB, Wedig MM, Conkey LC, Fitzmaurice GM. The course of marriage/sustained cohabitation and parenthood among borderline patients followed prospectively for 16 years. J Pers Disord. 2015 Feb; 29(1):62-70. PMID: 24963829; PMCID: PMC4276730; DOI: 10.1521/pedi_2014_28_147;

Frankenburg FR, Fitzmaurice GM, Zanarini MC. The use of prescription opioid medication by patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study. J Clin Psychiatry. 2014 Apr; 75(4):357-61. PMID: 24500123; PMCID: PMC4019694; DOI: 10.4088/JCP.13m08557;

Karan E, Niesten IJ, Frankenburg FR, Fitzmaurice GM, Zanarini MC. The 16-year course of shame and its risk factors in patients with borderline personality disorder. Personal Ment Health. 2014 Aug; 8(3):169-77. PMID: 24599878; PMCID: PMC4127149; DOI: 10.1002/pmh.1258;

Zanarini MC, Frankenburg FR, Reich DB, Wedig MM, Conkey LC, Fitzmaurice GM. Prediction of time-to-attainment of recovery for borderline patients followed prospectively for 16 years. Acta Psychiatr Scand. 2014 Sep; 130(3):205-13. PMID: 24588583; PMCID: PMC4138279; DOI: 10.1111/acps.12255;

Niesten IJ, Karan E, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Prevalence and risk factors for irritable bowel syndrome in recovered and non-recovered borderline patients over 10?years of prospective follow-up. Personal Ment Health. 2014 Feb; 8(1):14-23. PMID: 24532551; PMCID: PMC3927229; DOI: 10.1002/pmh.1237;

Plante DT, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Relationship between maladaptive cognitions about sleep and recovery in patients with borderline personality disorder. Psychiatry Res. 2013 Dec 30; 210(3):975-9. PMID: 23972789; PMCID: PMC3840073; DOI: 10.1016/j.psychres.2013.08.004;

Keuroghlian AS, Frankenburg FR, Zanarini MC. The relationship of chronic medical illnesses, poor health-related lifestyle choices, and health care utilization to recovery status in borderline patients over a decade of prospective follow-up. J Psychiatr Res. 2013 Oct; 47(10):1499-506. PMID: 23856083; PMCID: PMC3884821; DOI: 10.1016/j.jpsychires.2013.06.012;

Zanarini MC, Laudate CS, Frankenburg FR, Wedig MM, Fitzmaurice G. Reasons for self-mutilation reported by borderline patients over 16 years of prospective follow-up. J Pers Disord. 2013 Dec; 27(6):783-94. PMID: 23795756; PMCID: PMC3876880; DOI: 10.1521/pedi_2013_27_115;

Wedig MM, Frankenburg FR, Bradford Reich D, Fitzmaurice G, Zanarini MC. Predictors of suicide threats in patients with borderline personality disorder over 16 years of prospective follow-up. Psychiatry Res. 2013 Aug 15; 208(3):252-6. PMID: 23747235; PMCID: PMC3876888; DOI: 10.1016/j.psychres.2013.05.009;

Zanarini MC, Frankenburg FR, Wedig MM, Fitzmaurice GM. Cognitive experiences reported by patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry. 2013 Jun; 170(6):671-9. PMID: 23558452; PMCID: PMC3674122; DOI: 10.1176/appi.ajp.2013.13010055;

Plante DT, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Relationship between sleep disturbance and recovery in patients with borderline personality disorder. J Psychosom Res. 2013 Apr; 74(4):278-82. PMID: 23497827; PMCID: PMC3603271; DOI: 10.1016/j.jpsychores.2013.01.006;

Zanarini MC, Frankenburg FR, Fitzmaurice G. Defense mechanisms reported by patients with borderline personality disorder and axis II comparison subjects over 16 years of prospective follow-up: description and prediction of recovery. Am J Psychiatry. 2013 Jan; 170(1):111-20. PMID: 23223866; PMCID: PMC3537850; DOI: 10.1176/appi.ajp.2012.12020173;

Silverman MH, Frankenburg FR, Reich DB, Fitzmaurice G, Zanarini MC. The course of anxiety disorders other than PTSD in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. J Pers Disord. 2012 Oct; 26(5):804-14. PMID: 23013347; PMCID: PMC3551625; DOI: 10.1521/pedi.2012.26.5.804;

Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry. 2012 May; 169(5):476-83. PMID: 22737693; PMCID: PMC3509999; DOI: 10.1176/appi.ajp.2011.11101550;

McGowan A, King H, Frankenburg FR, Fitzmaurice G, Zanarini MC. The course of adult experiences of abuse in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. J Pers Disord. 2012 Apr; 26(2):192-202. PMID: 22486449; PMCID: PMC3325504; DOI: 10.1521/pedi.2012.26.2.192;

Wedig MM, Silverman MH, Frankenburg FR, Reich DB, Fitzmaurice G, Zanarini MC. Predictors of suicide attempts in patients with borderline personality disorder over 16 years of prospective follow-up. Psychol Med. 2012 Nov; 42(11):2395-404. PMID: 22436619; PMCID: PMC3600404; DOI: 10.1017/S0033291712000517;

Frankenburg FR, Zanarini MC. Relationship between cumulative BMI and symptomatic, psychosocial, and medical outcomes in patients with borderline personality disorder. J Pers Disord. 2011 Aug; 25(4):421-31. PMID: 21838559; PMCID: PMC3203730; DOI: 10.1521/pedi.2011.25.4.421;

Zanarini MC, Hörz S, Frankenburg FR, Weingeroff J, Reich DB, Fitzmaurice G. The 10-year course of PTSD in borderline patients and axis II comparison subjects. Acta Psychiatr Scand. 2011 Nov; 124(5):349-56. PMID: 21564040; PMCID: PMC3203727; DOI: 10.1111/j.1600-0447.2011.01717.x;

Zanarini MC, Laudate CS, Frankenburg FR, Reich DB, Fitzmaurice G. Predictors of self-mutilation in patients with borderline personality disorder: A 10-year follow-up study. J Psychiatr Res. 2011 Jun; 45(6):823-8. PMID: 21129758; PMCID: PMC3203731; DOI: 10.1016/j.jpsychires.2010.10.015;

Zanarini MC, Frankenburg FR, Frankenbur FR, Weingeroff JL, Reich DB, Fitzmaurice GM, Weiss RD. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. Addiction. 2011 Feb; 106(2):342-8. PMID: 21083831; PMCID: PMC3222933; DOI: 10.1111/j.1360-0443.2010.03176.x;

Hörz S, Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Ten-year use of mental health services by patients with borderline personality disorder and with other axis II disorders. Psychiatr Serv. 2010 Jun; 61(6):612-6. PMID: 20513685; PMCID: PMC3889171; DOI: 10.1176/appi.ps.61.6.612;

Choi-Kain LW, Zanarini MC, Frankenburg FR, Fitzmaurice GM, Reich DB. A longitudinal study of the 10-year course of interpersonal features in borderline personality disorder. J Pers Disord. 2010 Jun; 24(3):365-76. PMID: 20545500; PMCID: PMC3222950; DOI: 10.1521/pedi.2010.24.3.365;

Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Time to attainment of recovery from borderline personality disorder and stability of recovery: A 10-year prospective follow-up study. Am J Psychiatry. 2010 Jun; 167(6):663-7. PMID: 20395399; PMCID: PMC3203735; DOI: 10.1176/appi.ajp.2009.09081130;

Zanarini MC, Reichman CA, Frankenburg FR, Reich DB, Fitzmaurice G. The course of eating disorders in patients with borderline personality disorder: a 10-year follow-up study. Int J Eat Disord. 2010 Apr; 43(3):226-32. PMID: 19343799; PMCID: PMC2839025; DOI: 10.1002/eat.20689;

Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. The 10-year course of psychosocial functioning among patients with borderline personality disorder and axis II comparison subjects. Acta Psychiatr Scand. 2010 Aug; 122(2):103-9. PMID: 20199493; PMCID: PMC3876887; DOI: 10.1111/j.1600-0447.2010.01543.x;

Plante DT, Zanarini MC, Frankenburg FR, Fitzmaurice GM. Sedative-hypnotic use in patients with borderline personality disorder and axis II comparison subjects. J Pers Disord. 2009 Dec; 23(6):563-71. PMID: 20001175; PMCID: PMC3222941; DOI: 10.1521/pedi.2009.23.6.563;

Zanarini MC, Barison LK, Frankenburg FR, Reich DB, Hudson JI. Family history study of the familial coaggregation of borderline personality disorder with axis I and nonborderline dramatic cluster axis II disorders. J Pers Disord. 2009 Aug; 23(4):357-69. PMID: 19663656; PMCID: PMC3203728; DOI: 10.1521/pedi.2009.23.4.357;

Zanarini MC, Jacoby RJ, Frankenburg FR, Reich DB, Fitzmaurice G. The 10-year course of social security disability income reported by patients with borderline personality disorder and axis II comparison subjects. J Pers Disord. 2009 Aug; 23(4):346-56. PMID: 19663655; PMCID: PMC3222934; DOI: 10.1521/pedi.2009.23.4.346;

Frankenburg FR. Folate supplementation: is it safe and effective? J Clin Psychiatry. 2009 May; 70(5):767; author reply 767-9. PMID: 19552872

Zanarini MC, Weingeroff JL, Frankenburg FR. Defense mechanisms associated with borderline personality disorder. J Pers Disord. 2009 Apr; 23(2):113-21. PMID: 19379090; PMCID: PMC3203733; DOI: 10.1521/pedi.2009.23.2.113;

Zanarini MC, Frankenburg FR, Jager-Hyman S, Reich DB, Fitzmaurice G. The course of dissociation for patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study. Acta Psychiatr Scand. 2008 Oct; 118(4):291-6. PMID: 18759803; PMCID: PMC3876894; DOI: 10.1111/j.1600-0447.2008.01247.x;

Frankenburg FR. Alcohol use, thiamine deficiency, and cognitive impairment. JAMA. 2008 Jun 25; 299(24):2854; author reply 2854-5. PMID: 18577727

Zanarini MC, Frankenburg FR. A preliminary, randomized trial of psychoeducation for women with borderline personality disorder. J Pers Disord. 2008 Jun; 22(3):284-90. PMID: 18540800

Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G, Weinberg I, Gunderson JG. The 10-year course of physically self-destructive acts reported by borderline patients and axis II comparison subjects. Acta Psychiatr Scand. 2008 Mar; 117(3):177-84. PMID: 18241308; PMCID: PMC3884820; DOI: 10.1111/j.1600-0447.2008.01155.x;

Frankenburg FR, Baldessarini RJ. Neurosyphilis, malaria, and the discovery of antipsychotic agents. Harv Rev Psychiatry. 2008; 16(5):299-307. PMID: 18803105

Zanarini MC, Frankenburg FR. The essential nature of borderline psychopathology. J Pers Disord. 2007 Oct; 21(5):518-35. PMID: 17953504

Frankenburg FR. The role of one-carbon metabolism in schizophrenia and depression. Harv Rev Psychiatry. 2007 Jul-Aug; 15(4):146-60. PMID: 17687709

Zanarini MC, Frankenburg FR, Reich DB, Silk KR, Hudson JI, McSweeney LB. The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study. Am J Psychiatry. 2007 Jun; 164(6):929-35. PMID: 17541053

Frankenburg FR, Zanarini MC. Personality disorders and medical comorbidity. Curr Opin Psychiatry. 2006 Jul; 19(4):428-31. PMID: 16721176

Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry. 2006 May; 163(5):827-32. PMID: 16648323

Zanarini MC, Frankenburg FR, Ridolfi ME, Jager-Hyman S, Hennen J, Gunderson JG. Reported childhood onset of self-mutilation among borderline patients. J Pers Disord. 2006 Feb; 20(1):9-15. PMID: 16563075

Frankenburg FR, Zanarini MC. Obesity and obesity-related illnesses in borderline patients. J Pers Disord. 2006 Feb; 20(1):71-80. PMID: 16563080

Frankenburg FR. Smoking cessation. JAMA. 2005 Nov 16; 294(19):2434; author reply 2435. PMID: 16287951

Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow-up. J Pers Disord. 2005 Oct; 19(5):505-23. PMID: 16274279

Zanarini MC, Frankenburg FR, Reich DB, Hennen J, Silk KR. Adult experiences of abuse reported by borderline patients and Axis II comparison subjects over six years of prospective follow-up. J Nerv Ment Dis. 2005 Jun; 193(6):412-6. PMID: 15920382

Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years. J Pers Disord. 2005 Feb; 19(1):19-29. PMID: 15899718

Zanarini MC, Frankenburg FR, Vujanovic AA, Hennen J, Reich DB, Silk KR. Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission. Acta Psychiatr Scand. 2004 Dec; 110(6):416-20. PMID: 15521825

Frankenburg FR, Zanarini MC. The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry. 2004 Dec; 65(12):1660-5. PMID: 15641871

Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry. 2004 Nov; 161(11):2108-14. PMID: 15514413

Zanarini MC, Frankenburg FR, Yong L, Raviola G, Bradford Reich D, Hennen J, Hudson JI, Gunderson JG. Borderline psychopathology in the first-degree relatives of borderline and axis II comparison probands. J Pers Disord. 2004 Oct; 18(5):439-47. PMID: 15519954

Frankenburg FR. Pharmacological treatment of delirium in the intensive care unit. JAMA. 2004 Jul 14; 292(2):168; author reply 168-9. PMID: 15249562

Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry. 2004 Jul; 65(7):903-7. PMID: 15291677

Zanarini MC, Frankenburg FR, Hennen J, Silk KR. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry. 2004 Jan; 65(1):28-36. PMID: 14744165

Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Pers Disord. 2003 Dec; 17(6):568-73. PMID: 14744082

Zanarini MC, Parachini EA, Frankenburg FR, Holman JB, Hennen J, Reich DB, Silk KR. Sexual relationship difficulties among borderline patients and axis II comparison subjects. J Nerv Ment Dis. 2003 Jul; 191(7):479-82. PMID: 12891097

Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord. 2003 Jun; 17(3):233-42. PMID: 12839102

Zanarini MC, Frankenburg FR, Hennen J, Silk KR. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry. 2003 Feb; 160(2):274-83. PMID: 12562573

Zanarini MC, Frankenburg FR. omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry. 2003 Jan; 160(1):167-9. PMID: 12505817

Zanarini MC, Frankenburg FR, Vujanovic AA. Inter-rater and test-retest reliability of the Revised Diagnostic Interview for Borderlines. J Pers Disord. 2002 Jun; 16(3):270-6. PMID: 12136682

Zanarini MC, Yong L, Frankenburg FR, Hennen J, Reich DB, Marino MF, Vujanovic AA. Severity of reported childhood sexual abuse and its relationship to severity of borderline psychopathology and psychosocial impairment among borderline inpatients. J Nerv Ment Dis. 2002 Jun; 190(6):381-7. PMID: 12080208

Frankenburg FR, Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. J Clin Psychiatry. 2002 May; 63(5):442-6. PMID: 12019669

Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry. 2001 Nov; 62(11):849-54. PMID: 11775043

Zanarini MC, Frankenburg FR. Attainment and maintenance of reliability of axis I and II disorders over the course of a longitudinal study. Compr Psychiatry. 2001 Sep-Oct; 42(5):369-74. PMID: 11559863

Zanarini MC, Frankenburg FR, Khera GS, Bleichmar J. Treatment histories of borderline inpatients. Compr Psychiatry. 2001 Mar-Apr; 42(2):144-50. PMID: 11244151

Zanarini MC, Ruser T, Frankenburg FR, Hennen J. The dissociative experiences of borderline patients. Compr Psychiatry. 2000 May-Jun; 41(3):223-7. PMID: 10834632

Zanarini MC, Frankenburg FR, Reich DB, Marino MF, Lewis RE, Williams AA, Khera GS. Biparental failure in the childhood experiences of borderline patients. J Pers Disord. 2000; 14(3):264-73. PMID: 11019749

Zanarini MC, Ruser TF, Frankenburg FR, Hennen J, Gunderson JG. Risk factors associated with the dissociative experiences of borderline patients. J Nerv Ment Dis. 2000 Jan; 188(1):26-30. PMID: 10665457

Zanarini MC, Frankenburg FR, Reich DB, Marino MF, Haynes MC, Gunderson JG. Violence in the lives of adult borderline patients. J Nerv Ment Dis. 1999 Feb; 187(2):65-71. PMID: 10067945

Frankenburg FR. Choices in antipsychotic therapy in schizophrenia. Harv Rev Psychiatry. 1999 Jan-Feb; 6(5):241-9. PMID: 10372289

Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V. Axis I comorbidity of borderline personality disorder. Am J Psychiatry. 1998 Dec; 155(12):1733-9. PMID: 9842784

Zanarini MC, Frankenburg FR, DeLuca CJ, Hennen J, Khera GS, Gunderson JG. The pain of being borderline: dysphoric states specific to borderline personality disorder. Harv Rev Psychiatry. 1998 Nov-Dec; 6(4):201-7. PMID: 10370445

Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V. Axis II comorbidity of borderline personality disorder. Compr Psychiatry. 1998 Sep-Oct; 39(5):296-302. PMID: 9777282

Frankenburg FR, Zanarini MC, Kando J, Centorrino F. Clozapine and body mass change. Biol Psychiatry. 1998 Apr 01; 43(7):520-4. PMID: 9547931

Zanarini MC, Williams AA, Lewis RE, Reich RB, Vera SC, Marino MF, Levin A, Yong L, Frankenburg FR. Reported pathological childhood experiences associated with the development of borderline personality disorder. Am J Psychiatry. 1997 Aug; 154(8):1101-6. PMID: 9247396

Zanarini MC, Frankenburg FR. Pathways to the development of borderline personality disorder. J Pers Disord. 1997; 11(1):93-104. PMID: 9113824

Rabinowitz T, Frankenburg FR, Centorrino F, Kando J. The effect of clozapine on saliva flow rate: a pilot study. Biol Psychiatry. 1996 Dec 01; 40(11):1132-4. PMID: 8931916

Frankenburg FR, Kalunian D. Cardiorespiratory problems with clozapine. J Clin Psychiatry. 1996 Nov; 57(11):548-9. PMID: 8968308

Centorrino F, Baldessarini RJ, Frankenburg FR, Kando J, Volpicelli SA, Flood JG. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am J Psychiatry. 1996 Jun; 153(6):820-2. PMID: 8633698

Frankenburg FR, Kando JC, Centorrino F, Gilbert JM. Bladder dysfunction associated with clozapine therapy. J Clin Psychiatry. 1996 Jan; 57(1):39-40. PMID: 8543547

Nitenson NC, Kando JC, Frankenburg FR, Zanarini MC. Fever associated with clozapine administration. Am J Psychiatry. 1995 Jul; 152(7):1102. PMID: 7793458

Friedberg JW, Frankenburg FR, Burk J, Johnson W. Clozapine-caused eosinophilic colitis. Ann Clin Psychiatry. 1995 Jun; 7(2):97-8. PMID: 8556100

Centorrino F, Baldessarini RJ, Flood JG, Kando JC, Frankenburg FR. Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites. Am J Psychiatry. 1995 Apr; 152(4):610-2. PMID: 7694912

Frankenburg FR, Stormberg D, Gerson SL. Unsuccessful reexposure to clozapine. J Clin Psychopharmacol. 1994 Dec; 14(6):428-9. PMID: 7884027

Frankenburg FR, Hegarty JD. Tinnitus, psychosis, and suicide. Arch Intern Med. 1994 Oct 24; 154(20):2371, 2375. PMID: 7944860

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 106 publications over 30 distinct years, with a maximum of 8 publications in 2013 and 2014

Bar chart showing 106 publications over 30 distinct years, with a maximum of 8 publications in 2013 and 2014

Year	Publications
1994	2
1995	3
1996	4
1997	2
1998	4
1999	2
2000	3
2001	3
2002	3
2003	5
2004	7
2005	4
2006	4
2007	3
2008	5
2009	5
2010	7
2011	2
2012	4
2013	8
2014	8
2015	2
2016	3
2017	1
2018	3
2019	5
2020	1
2021	1
2022	1
2023	1

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Borderline Personality Disorder

Contact for Mentoring:

781.687.3004

Download vCard

Frankenburg's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (305) concept(s)

Similar People

See all (60) people

Same Department

Search Department